Analyst firms · H.C. Wainwright · AVDL

H.C. Wainwright AVDL price target and rating history

Avadel Pharmaceuticals plc (AVDL) · Health Care

H.C. Wainwright rates Avadel Pharmaceuticals plc (AVDL) Neutral with a $20 price target, as of its latest action on Oct 23, 2025. It has published 3 rating actions on AVDL since March 2024, including 0 upgrades and 1 downgrade.

Current rating
Neutral
Price target
$20
Median target, all firms
Too few
Actions on AVDL
3

H.C. Wainwright price target on AVDL

$25$23$2020252026
H.C. Wainwright price target on AVDL, each point a stated target, March 2024 to October 2025.

Every H.C. Wainwright rating on AVDL

Questions about H.C. Wainwright and AVDL

What is H.C. Wainwright's price target for AVDL?
H.C. Wainwright's latest stated price target for Avadel Pharmaceuticals plc (AVDL) is $20, from its action on Oct 23, 2025.
What is H.C. Wainwright's rating on AVDL?
H.C. Wainwright rates AVDL Neutral, a neutral rating, as of Oct 23, 2025.
When did H.C. Wainwright last change its view on AVDL?
On Oct 23, 2025, H.C. Wainwright downgrades to Neutral from Buy, price target $20.

More AVDL rating histories

All H.C. Wainwright ratingsAVDL news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.